PEPG Stock Price
PepGen Inc.
PEPG stock price is $5.37 (+124.69% on the day), giving PepGen Inc. a market cap of $171.07M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
PEPG Stock Overview
- Price
- $5.37
- Previous close
- $2.39
- Open
- $5.54
- Market cap
- $171.07M
- 52-week range
- $1.31 - $7.80
- 1-year price target
- $10.19
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 35
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PEPG | $5.37 | +124.7% | 84.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |